Can Fite Biopharma ADR Representing 300 Ord Shs (CANF) stock is down -71.26% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CANF stock a score of 32 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 9. CANF's rank also includes a long-term technical score of 12.
CANF has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on CANF!
Can Fite Biopharma ADR Representing 300 Ord Shs (CANF) stock is trading at $2.40 as of 1:33 PM on Tuesday, Nov 21, a gain of $0.39, or 19.7% from the previous closing price of $2.01. Volume today is more active than usual. So far 2,895,160 shares have traded compared to average volume of 6,577 shares. The stock has traded between $2.10 and $2.69 so far today.
Click Here to get the full Stock Report for Can Fite Biopharma ADR Representing 300 Ord Shs stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
